Cargando…

Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury

Objective  Alveolar macrophages play a key role in the development and resolution of acute respiratory distress syndrome (ARDS), modulating the inflammatory response and the coagulation cascade in lungs. Anti-coagulants may be helpful in the treatment of ARDS. This study investigated the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimenti, Laura, Camprubí-Rimblas, Marta, Guillamat-Prats, Raquel, Gomez, Maria Nieves, Tijero, Jessica, Blanch, Lluis, Artigas, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328369/
https://www.ncbi.nlm.nih.gov/pubmed/29202212
http://dx.doi.org/10.1160/TH17-05-0347
_version_ 1783386635837112320
author Chimenti, Laura
Camprubí-Rimblas, Marta
Guillamat-Prats, Raquel
Gomez, Maria Nieves
Tijero, Jessica
Blanch, Lluis
Artigas, Antonio
author_facet Chimenti, Laura
Camprubí-Rimblas, Marta
Guillamat-Prats, Raquel
Gomez, Maria Nieves
Tijero, Jessica
Blanch, Lluis
Artigas, Antonio
author_sort Chimenti, Laura
collection PubMed
description Objective  Alveolar macrophages play a key role in the development and resolution of acute respiratory distress syndrome (ARDS), modulating the inflammatory response and the coagulation cascade in lungs. Anti-coagulants may be helpful in the treatment of ARDS. This study investigated the effects of nebulized heparin on the role of alveolar macrophages in limiting lung coagulation and inflammatory response in an animal model of acute lung injury (ALI). Methods  Rats were randomized to four experimental groups. In three groups, ALI was induced by intratracheal instillation of lipopolysaccharide (LPS) and heparin was nebulized at constant oxygen flow: the LPS/Hep group received nebulized heparin 4 and 8 hours after injury; the Hep/LPS/Hep group received nebulized heparin 30 minutes before and 4 and 8 hours after LPS-induced injury; the LPS/Sal group received nebulized saline 4 and 8 hours after injury. The control group received only saline. Animals were exsanguinated 24 hours after LPS instillation. Lung tissue, bronchoalveolar lavage fluid (BALF) and alveolar macrophages isolated from BALF were analysed. Results  LPS increased protein concentration, oedema and neutrophils in BALF as well as procoagulant and proinflammatory mediators in lung tissue and alveolar macrophages. In lung tissue, nebulized heparin attenuated ALI through decreasing procoagulant (tissue factor, thrombin–anti-thrombin complexes, fibrin degradation products) and proinflammatory (interleukin 6, tumour necrosis factor alpha) pathways. In alveolar macrophages, nebulized heparin reduced expression of procoagulant genes and the effectors of transforming growth factor beta (Smad 2, Smad 3) and nuclear factor kappa B (p-selectin, CCL-2). Pre-treatment resulted in more pronounced attenuation. Conclusion  Nebulized heparin reduced pulmonary coagulopathy and inflammation without producing systemic bleeding, partly by modulating alveolar macrophages.
format Online
Article
Text
id pubmed-6328369
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Schattauer GmbH
record_format MEDLINE/PubMed
spelling pubmed-63283692019-01-13 Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury Chimenti, Laura Camprubí-Rimblas, Marta Guillamat-Prats, Raquel Gomez, Maria Nieves Tijero, Jessica Blanch, Lluis Artigas, Antonio Thromb Haemost Objective  Alveolar macrophages play a key role in the development and resolution of acute respiratory distress syndrome (ARDS), modulating the inflammatory response and the coagulation cascade in lungs. Anti-coagulants may be helpful in the treatment of ARDS. This study investigated the effects of nebulized heparin on the role of alveolar macrophages in limiting lung coagulation and inflammatory response in an animal model of acute lung injury (ALI). Methods  Rats were randomized to four experimental groups. In three groups, ALI was induced by intratracheal instillation of lipopolysaccharide (LPS) and heparin was nebulized at constant oxygen flow: the LPS/Hep group received nebulized heparin 4 and 8 hours after injury; the Hep/LPS/Hep group received nebulized heparin 30 minutes before and 4 and 8 hours after LPS-induced injury; the LPS/Sal group received nebulized saline 4 and 8 hours after injury. The control group received only saline. Animals were exsanguinated 24 hours after LPS instillation. Lung tissue, bronchoalveolar lavage fluid (BALF) and alveolar macrophages isolated from BALF were analysed. Results  LPS increased protein concentration, oedema and neutrophils in BALF as well as procoagulant and proinflammatory mediators in lung tissue and alveolar macrophages. In lung tissue, nebulized heparin attenuated ALI through decreasing procoagulant (tissue factor, thrombin–anti-thrombin complexes, fibrin degradation products) and proinflammatory (interleukin 6, tumour necrosis factor alpha) pathways. In alveolar macrophages, nebulized heparin reduced expression of procoagulant genes and the effectors of transforming growth factor beta (Smad 2, Smad 3) and nuclear factor kappa B (p-selectin, CCL-2). Pre-treatment resulted in more pronounced attenuation. Conclusion  Nebulized heparin reduced pulmonary coagulopathy and inflammation without producing systemic bleeding, partly by modulating alveolar macrophages. Schattauer GmbH 2017-11 2017-11-30 /pmc/articles/PMC6328369/ /pubmed/29202212 http://dx.doi.org/10.1160/TH17-05-0347 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Chimenti, Laura
Camprubí-Rimblas, Marta
Guillamat-Prats, Raquel
Gomez, Maria Nieves
Tijero, Jessica
Blanch, Lluis
Artigas, Antonio
Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title_full Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title_fullStr Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title_full_unstemmed Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title_short Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury
title_sort nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328369/
https://www.ncbi.nlm.nih.gov/pubmed/29202212
http://dx.doi.org/10.1160/TH17-05-0347
work_keys_str_mv AT chimentilaura nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT camprubirimblasmarta nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT guillamatpratsraquel nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT gomezmarianieves nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT tijerojessica nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT blanchlluis nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury
AT artigasantonio nebulizedheparinattenuatespulmonarycoagulopathyandinflammationthroughalveolarmacrophagesinaratmodelofacutelunginjury